Search research articles
Contact Us
Filters
Showing results (11-20 of 59) with videos related to
Page
of 6
Sort By:
Occupational and Environmental Medicine
|
August 1, 1997
Risks of beryllium disease related to work processes at a metal, alloy, and oxide production plant
K Kreiss, M M Mroz, B Zhen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 24, 1999
Effect of CD34(+) cell dose on resource utilization in patients after high-dose chemotherapy with peripheral-blood stem-cell support
K A Schulman, R Birch, B Zhen, et al.
The Review of Scientific Instruments
|
July 26, 2024
Measurement of wing motion, deformation, and inertial forces of a biomimetic butterfly
A Yunjie Yang, B Zhen Wei, C Siyao Zeng, et al.
Seminars in Oncology
|
November 5, 2018
Biomarker-driven and molecularly targeted therapies for pancreatic adenocarcinoma
David B Zhen, Andrew Coveler, Silvia Zanon, et al.
American Journal of Industrial Medicine
|
July 1, 1996
Machining risk of beryllium disease and sensitization with median exposures below 2 micrograms/m3
K Kreiss, M M Mroz, L S Newman, et al.
Expert Review of Clinical Immunology
|
September 1, 2022
Combination immunotherapy for pancreatic cancer: challenges and future considerations
Gustavo C L Gössling, David B Zhen, Venu G Pillarisetty, et al.
American Journal of Industrial Medicine
|
October 1, 1997
Interaction of genetic and exposure factors in the prevalence of berylliosis
L Richeldi, K Kreiss, M M Mroz, et al.
The American Review of Respiratory Disease
|
October 1, 1993
Epidemiology of beryllium sensitization and disease in nuclear workers
K Kreiss, M M Mroz, B Zhen, et al.
Neoplasma
|
August 28, 2016
Gene expression profiling analysis of the role of miR-22 in clear cell ovarian cancer
Y B Zhen, X L Guo, B Xu, et al.
American Journal of Clinical Oncology
|
August 26, 1998
A randomized trial of mobilization of peripheral blood stem cells with cyclophosphamide, etoposide, and granulocyte colony-stimulating factor with or without cisplatin in patients with malignant lymphoma receiving high-dose chemotherapy
C H Weaver, B Zhen, L Schwartzberg, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 59) with videos related to
Sort By:
Page
of 6
Occupational and Environmental Medicine
|
August 1, 1997
Risks of beryllium disease related to work processes at a metal, alloy, and oxide production plant
K Kreiss, M M Mroz, B Zhen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 24, 1999
Effect of CD34(+) cell dose on resource utilization in patients after high-dose chemotherapy with peripheral-blood stem-cell support
K A Schulman, R Birch, B Zhen, et al.
The Review of Scientific Instruments
|
July 26, 2024
Measurement of wing motion, deformation, and inertial forces of a biomimetic butterfly
A Yunjie Yang, B Zhen Wei, C Siyao Zeng, et al.
Seminars in Oncology
|
November 5, 2018
Biomarker-driven and molecularly targeted therapies for pancreatic adenocarcinoma
David B Zhen, Andrew Coveler, Silvia Zanon, et al.
American Journal of Industrial Medicine
|
July 1, 1996
Machining risk of beryllium disease and sensitization with median exposures below 2 micrograms/m3
K Kreiss, M M Mroz, L S Newman, et al.
Expert Review of Clinical Immunology
|
September 1, 2022
Combination immunotherapy for pancreatic cancer: challenges and future considerations
Gustavo C L Gössling, David B Zhen, Venu G Pillarisetty, et al.
American Journal of Industrial Medicine
|
October 1, 1997
Interaction of genetic and exposure factors in the prevalence of berylliosis
L Richeldi, K Kreiss, M M Mroz, et al.
The American Review of Respiratory Disease
|
October 1, 1993
Epidemiology of beryllium sensitization and disease in nuclear workers
K Kreiss, M M Mroz, B Zhen, et al.
Neoplasma
|
August 28, 2016
Gene expression profiling analysis of the role of miR-22 in clear cell ovarian cancer
Y B Zhen, X L Guo, B Xu, et al.
American Journal of Clinical Oncology
|
August 26, 1998
A randomized trial of mobilization of peripheral blood stem cells with cyclophosphamide, etoposide, and granulocyte colony-stimulating factor with or without cisplatin in patients with malignant lymphoma receiving high-dose chemotherapy
C H Weaver, B Zhen, L Schwartzberg, et al.
Page
of 6